You are here

Article Text

Article menu
Download PDFPDF
Prognosis
Partial syndromes of eating disorders in adolescence are associated with adverse health outcome in adulthood

http://dx.doi.org/10.1136/ebmh.11.4.105

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    QUESTION

    Question:

    What impact do partial syndromes of eating disorder in adolescence have on health and social adjustment in young adulthood?

    Population:

    2032 students selected using a two-stage cluster sample and followed up regularly into young adulthood. In the first wave, one class from each of 44 schools was selected at random. A second class was randomly selected 6 months later (wave 2). The average age of participants at the start of study was 14.5 years. Follow-up was at subsequent 6-month intervals during the remaining school years (waves 3–6) and at two stages in young adulthood (wave 7, aged 20–21 years; wave 8, aged 24–25 years).

    Setting:

    Victoria, Australia; August 1992 to March 2003.

    Prognostic factors:

    Partial syndrome of eating disorder based on DSM-IV criteria for anorexia or bulimia on the Branched Eating Disorders Test. See online notes for further details on how anorexia and bulimia were defined.

    Outcomes:

    Depression or anxiety (assessed on the Revised Clinical Interview Schedule (CIS-R) during waves 1–7 and the 12-item General Health Questionnaire (GHQ) at wave 8), persistent eating disorder (assessed at wave 7 and …

    View Full Text

    Footnotes

    • Source of Funding: National Health and Medical Research Council, the Victorian Health Promotion Foundation, and the Victorian Centre for Excellence in Eating Disorders.

    • Additional notes and a reference list are published online only at http://ebmh.bmj.com/content/vol11/issue4

    Footnotes

    • Competing interests: PH has been sponsored by AstraZeneca to provide a lecture at an educational meeting for psychiatrists.